Search

M2 PRESSWIRE-January 8, 2025-: Myasthenia Gravis Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | Sanofi, Cartesian Therapeutics, Takeda, UCB Biopharma, Hoffmann-La Roche, Janssen R&D, Immunovant (C)1994-2025 [...]

M2 PRESSWIRE-December 5, 2024-: Fibrodysplasia Ossificans Progressiva Therapeutics Market Size was ~USD 6 million in 2022 in the 7MM, estimated DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:05122024 DelveInsight's 'Fibrodysplasia Ossificans Progressiva Market [...]

M2 PRESSWIRE-November 20, 2024-: Lipodystrophy Market Size in the 7MM is expected to grow by 2034, estimates DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:20112024 DelveInsight's 'Lipodystrophy Market Insights, Epidemiology and Market Forecast [...]

M2 PRESSWIRE-November 20, 2024-: Multiple Myeloma Market on Track for Major Expansion by 2034, According to DelveInsight | Janssen Pharma, Regeneron Pharma, Johnson & Johnson Innovative Medicine, Bristol Myers Squibb, [...]

M2 PRESSWIRE-November 13, 2024-: Chronic Obstructive Pulmonary Disease Market Size was valued at USD 16,075 million in 2023, estimated DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:13112024 DelveInsight's 'Chronic Obstructive Pulmonary Disease Market [...]

After over a decade without notable progress in treating chronic obstructive pulmonary disease, patients with this ongoing condition now have two new treatment options, with more expected in the future. [...]

M2 PRESSWIRE-November 11, 2024-: Allergic Rhinitis Treatment Market Size in the 7MM is expected to Grow by 2034 | DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:11112024 DelveInsight's 'Allergic Rhinitis Market Insights, Epidemiology, [...]

M2 PRESSWIRE-November 5, 2024-: Non-Alcoholic Steatohepatitis Market to Show Remarkable Growth Trends from 2023 to 2032, DelveInsight Reports | Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Viking Therapeutics, Madrigal (C)1994-2024 [...]

M2 PRESSWIRE-October 7, 2024-: Age-related Macular Degeneration (AMD) Drugs Market to Hit $17.37 Billion by 2029 (C)1994-2024 M2 COMMUNICATIONS RDATE:04102024 Companies within the AMD drugs market are researching newer drug [...]

HARRISBURG, PA -- The following information was released by the Pennsylvania State Senator Bob Mensch: By: Sen. Bob Mensch In 2024, investors should keep a close eye on Vertex Pharmaceuticals [...]

The medical dynamometers market is predicted to surge owing to the rise in bone-related conditions like osteoporosis and arthritis, along with an uptick in sports injuries and the expanding elderly [...]

M2 PRESSWIRE-April 26, 2024-: Cholestatic Pruritus Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Escient Pharma, GlaxoSmithKline, Mirum Pharma, Albireo, Regeneron Pharma (C)1994-2024 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-April 26, 2024-: Cutaneous Squamous Cell Carcinoma Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Incyte Crp, Merck Sharp, Regeneron Pharma, Replimune [...]

M2 PRESSWIRE-April 26, 2024-: Allergic Rhinitis Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Regeneron Pharma, Allergy Therapeutics, Inmunotek, UCB Pharma, Orexo AB, Hyloris (C)1994-2024 [...]

M2 PRESSWIRE-April 25, 2024-: Multiple Myeloma Market size was USD 21,300 million in 2023, estimates DelveInsight | GlaxoSmithKline, Bristol-Myers Squibb, Bluebird bio, Oncopeptides AB, Secura Bio, Amgen, Takeda, Pfizer, more [...]

M2 PRESSWIRE-April 11, 2024-: Eosinophilic Esophagitis Market to Exhibit Rapid Growth During the Forecast Period (2024-2034), Investigates DelveInsight | Regeneron Pharma, Sanofi, Bristol-Myers Squibb, Ellodi Pharma, AstraZeneca (C)1994-2024 M2 COMMUNICATIONS [...]

The HPV 16+ cancer market size is anticipated to increase due to an increase in the research and development programs related to HPV 16+ cancer in recent years. Future research [...]

M2 PRESSWIRE-March 20, 2024-: Multiple Myeloma Market Trends & Forecasts 2032 | Drug Pipeline, FDA Approvals, and companies by DelveInsight | GSK, BMS, Bluebird bio, Oncopeptides AB, Secura Bio, Amgen, [...]

M2 PRESSWIRE-March 20, 2024-: Atopic Dermatitis Market Forecast 2032: Treatment Therapies, FDA Approvals, Patient Pool, Leading Companies by DelveInsight | Sanofi, Regeneron, Pfizer, Japan Tobacco, Torii Pharmaceutical, Eli Lilly (C)1994-2024 [...]

M2 PRESSWIRE-March 19, 2024-: Birch Allergy Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | ALK-Abelló A/S, Allergy Therapeutics Plc., Regeneron Pharmaceuticals Inc., Desentum (C)1994-2024 M2 [...]

M2 PRESSWIRE-March 19, 2024-: Bullous Pemphigoid Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | AstraZeneca, AKARI Therapeutics, Regeneron Pharma, Argenx (C)1994-2024 M2 COMMUNICATIONS RDATE:18032024 [...]

M2 PRESSWIRE-March 12, 2024-: Nasal Polyposis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | AstraZeneca, Amgen, Keymed Biosciences, GlaxoSmithKline, Sanofi, Regeneron (C)1994-2024 M2 [...]

M2 PRESSWIRE-March 6, 2024-: Atopic Dermatitis Market to grow significantly by 2032 | Sanofi, Regeneron Pharmaceuticals, Pfizer, Japan Tobacco and Torii Pharmaceutical, Eli Lilly and Company, and others. (C)1994-2024 M2 [...]

M2 PRESSWIRE-February 12, 2024-: Cutaneous Melanoma Market Size in 7MM is Anticipated to See a Significant Change by 2032 (C)1994-2024 M2 COMMUNICATIONS RDATE:12022024 'There has been an increase in the [...]

M2 PRESSWIRE-January 30, 2024-: Regeneron Pharmaceuticals/Sanofi Genzyme's Dupilumab market size expected to increase many folds by 2032, report DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:29012024 Dupilumab Market Size, Forecast, and Emerging Insight [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Relapsing/Refractory Multiple Myeloma Market Insights report includes a comprehensive understanding of current treatment practices, R/R multiple myeloma [...]

The dynamics of relapsed/refractory multiple myeloma market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, incremental healthcare spending across the world, and [...]

Chicago, Jan. 04, 2024 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=1zPsS2fV0jSqIhhwrvzIjbqe6wBNGfafV5OVe8wB-l_XOBgE5g2ZmnySxOPqaHsMzF_nyJ0Xg6axSZvuu83tMjwpUNN3WYavGMspds9xqc5AYJ2nAbNvkQQSe8AR_WNbAhjRvKuGiasKr5993ZrXlcLn84VHldBljzWn5mk0Prtgm6MNPb5e0STfgoh-KRhok3ONwCrCdVws3gHQEXBJG4acrhPXVhN2EjqHrBHAcdgBtbMEW2XAXAmTkDr-d-dce3tNPg_aSfHAkwjhpGWPIOd2lf5BUeLpia4_wNyXCb0= in terms of revenue was estimated to be worth $247.3 Billion in 2023 and is poised to reach $479.0 billion by 2028, [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Cutaneous Squamous Cell Carcinoma Market Insights report includes a comprehensive understanding of current treatment practices, cutaneous squamous [...]

M2 PRESSWIRE-December 14, 2023-: Chronic Obstructive Pulmonary Disease Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron (C)1994-2023 M2 [...]

The dynamics of the cutaneous squamous cell carcinoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the disease, [...]

CHICAGO, Dec. 7, 2023 /PRNewswire/ --https://www.marketsandmarkets.com/Market-Reports/antibody-therapeutics-market-178852478.html?utm_source=Prnewswire&utm_medium=referral&utm_campaign=paidpr in terms of revenue was estimated to be worth $247.3 billion in 2023 and is poised to reach $479.0 billion by 2028, growing at [...]

M2 PRESSWIRE-November 29, 2023-: DelveInsight Explores Septic Shock Market Forecasts (2023-2032) Featuring Regeneron Pharma, Merck Sharp & Dohme LLC, Shionogi Inc., Sentien Biotech, and Basilea (C)1994-2023 M2 COMMUNICATIONS RDATE:28112023 (Albany, [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Metastatic Non-small Cell Lung Cancer Market Insights report includes a comprehensive understanding of current country-specific treatment practices, [...]

The metastatic non-small cell lung cancer market size is expected to witness a revolutionary change in the coming decade owing to the increase in incident cases of NSCLC, continuous uptake [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: B-cell lymphoma is a diverse group of blood cancers that originate from abnormal B lymphocytes, a type of [...]

B-cell lymphoma, a subtype of non-Hodgkin lymphoma, stands as the leading cancer diagnosis in the United States, comprising 85% of all cases. This cancer targets the lymphatic system, encompassing lymph [...]

NEW YORK, Nov. 9, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/anti-cd20-monoclonal-antibodies-mabs-market-size-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=T2023_VRD_wk45_2023_019_rep&utm_content=IRTNTR71141 is expected to grow byUSD 11.42 billion from 2023 to 2028. In addition, the momentum of the market will progress at aCAGR [...]

M2 PHARMA-February 28, 2024-Langerhans Cell Histiocytosis Market and Epidemiology Report 2032, by DelveInsight | Adimab, Innovent Biologics, Affimed, Novartis, Amgen, AstraZeneca, Sanofi, Roche, Regeneron, Eli Lilly (C)2024 M2 COMMUNICATIONS 'Langerhans [...]

M2 EQUITYBITES-February 28, 2024-Langerhans Cell Histiocytosis Market and Epidemiology Report 2032, by DelveInsight | Adimab, Innovent Biologics, Affimed, Novartis, Amgen, AstraZeneca, Sanofi, Roche, Regeneron, Eli Lilly (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk [...]

M2 PRESSWIRE-October 17, 2023-: Prurigo Nodularis Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | Trevi Therapeutics, Galderma, Genentech, Incyte Crp., Vyne Therapeutics, Celgene (C)1994-2023 [...]

M2 PRESSWIRE-October 16, 2023-: Acute Pancreatitis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | CalciMedica, Inc, Regeneron Pharma, Pfizer, Repligen [...]

M2 PRESSWIRE-October 12, 2023-: Next Generation Immunotherapies Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | GlaxoSmithKline, Roche, Regeneron Pharma, Boehringer (C)1994-2023 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-October 6, 2023-: Multiple Myeloma Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Roche, AbbVie, Amgen, Sanofi, Pfizer, Janssen Pharma, Regeneron Pharma [...]

M2 PRESSWIRE-October 5, 2023-: Allergic Rhinitis Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - Regeneron Pharmaceuticals, Inmunotek, AOBiome, Emergo Therapeutics (C)1994-2023 M2 [...]

M2 PRESSWIRE-September 26, 2023-: Rhinitis Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - EMS, Regeneron Pharmaceuticals, ALK-Abelló A/S, Bayer, Inmunotek S.L (C)1994-2023 [...]

NEW YORK, Sept. 18, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/myopia-and-presbyopia-treatment-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=t_2023_vrd_wk38_2023_020_rep&utm_content=IRTNTR74159 size is expected to grow byUSD 7.94 billion from 2022 to 2027. In addition, the momentum of the market will progress at [...]

M2 PRESSWIRE-September 6, 2023-: Fibrodysplasia Ossificans Progressiva Market: Epidemiology Insights, Pipeline Products, and Key Companies Working in the Market | Companies - Ipsen, Regeneron Pharmaceuticals, Ipsen, BioCryst (C)1994-2023 M2 COMMUNICATIONS [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Allergic Conjunctivitis Market Insights report includes a comprehensive understanding of current treatment practices, allergic conjunctivitis emerging drugs, [...]

The allergic conjunctivitis market is anticipated to grow in the coming years owing to the increased prevalence, better disease understanding along with the current advancements in the treatment. LAS VEGAS, [...]